OXIGENE INC·4

Aug 1, 8:35 PM ET

LANGECKER PETER 4

4 · OXIGENE INC · Filed Aug 1, 2012

Insider Transaction Report

Form 4
Period: 2012-07-30
LANGECKER PETER
Chief Development Officer
Transactions
  • Award

    Stock Option (Right to Buy)

    2012-07-30+100,000100,000 total
    Exercise: $0.55From: 2012-07-30Exp: 2022-07-30Common Stock (100,000 underlying)
Footnotes (1)
  • [F1]The Stock Option vests semi-annually in eight equal installments of 12,500 shares beginning six months following the grant date, on January 30, 2013.

Documents

1 file
  • 4
    rrd352107.xmlPrimary